Embryonic stem (ES) cells are characterized by two distinguishing attributes: their ability to adopt any cell fate (pluripotency) and their unlimited capacity for self-renewal. These unique abilities are maintained by a core network of transcription factors, including OCT4, SOX2, NANOG, and KLF4, that cooperate in complex regulatory circuits to ensure appropriate ES cell behavior. The importance of posttranscriptional control in diverse biological processes suggests an additional level of regulation of stem cell phenotypes. Indeed, numerous lines of evidence now implicate the microRNA (miRNA) family of posttranscriptional regulators as central players in the maintenance of normal ES cell function. Now, Xu et al. (2009) report in this issue of Cell that miR-145, an miRNA induced during differentiation, directly silences the stem cell selfrenewal and pluripotency program.
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Genetic disruption of the essential miRNA biogenesis factors Dicer and Dgcr8 in the mouse results in numerous defects in ES cell behavior, including impaired self-renewal, diminished expression of pluripotency markers, and a failure to execute induced programs of differentiation (Kim, 2008) . Recent studies have begun assigning the activity of specific miRNAs to these critical ES cell functions. For example, the miR-290 cluster (expressed in the mouse), the miR-371 cluster (expressed in humans), and the miR-302 cluster (expressed in both) are direct regulators of the cell cycle in ES cells (Figure 1) . Interestingly, the promoters of each of these miRNA clusters are bound by core ES cell transcription factors, and each cluster encodes miRNAs with a shared seed sequence that is very similar to that of the oncogenic miR-17 family. Repression of the cyclin-dependent kinase inhibitor Cdkn1a (p21), a shared target of these miRNAs, promotes rapid transit through the cell cycle, a key aspect of stem cell self-renewal.
Beyond this established role for miRNAs in ES cell proliferation, it is less clear whether miRNAs contribute to the restricted expression of pluripotency factors during stem cell differentiation. Recent work in murine ES cells has uncovered evidence for the miRNAmediated regulation of pluripotency factors (Tay et al., 2008) , but the extent and importance of endogenous miRNAs in the regulation of the human ES cell core transcriptional network remains unknown. In their new work, Xu et al. (2009) Given the proposed role for miR-145 in silencing the pluripotency program during ES cell differentiation, it is perhaps surprising that this miRNA also appears to repress pluripotency factors in undifferentiated stem cells. This suggests complementary, yet distinct, functions for this miRNA in stem cells versus differentiating cells. Maintenance of pluripotency in ES cells is highly sensitive to the dosage of transcriptional regulators such as OCT4 and SOX2, especially as their reciprocal activation can rapidly drive an irreversible positive feedback loop (Chew et al., 2005) . It is therefore likely that miR-145 buffers ES cells from such runaway activation cascades (Figure 1) , a function in line with current models in which miRNAs tune, rather than silence, expression of target genes. At the same time, reciprocal miR-145/OCT4 inhibition allows ES cells to activate a self-reinforcing switch that silences the self-renewal program in response to differentiation signals. Given this role for miR-145 in the switch from pluripotency to cell fate commitment, it is possible that inhibition of miR-145 might be a useful strategy to enhance the efficiency of generating induced pluripotent stem cells.
A number of important questions remain. Although Xu and colleagues demonstrate convincingly that OCT4 is bound to a region ?1 kb upstream of miR-145 and that this sequence has regulatory activity in reporter assays, direct OCT4-mediated regulation of endogenous miR-145 has yet to be established. Moreover, it is likely that the identified OCT4-bound cis-regulatory sequence is an enhancer element rather than a proximal promoter. Promoters for miRNAs are rarely located immediately upstream of the pre-miRNA encoding sequences and are often many kilobases removed in genomic space. Additionally, miR-145 is located in a cluster with miR-143, and therefore the two miRNAs are likely to be cotranscribed. Indeed, cloning data from a panel of murine and human tissues demonstrates that miR-143 is coexpressed in virtually all samples where miR-145 is detected, including ES cells (Landgraf et al., 2007) . Notably, the regulatory element described in this study is located between miR-143 and miR-145, suggesting that both miRNAs might be subject to repression by OCT4. In light of the genomic organization of these miRNAs, additional studies to investigate whether miR-143 regulates human ES cell pluripotency and differentiation are warranted.
The identification of miR-145 as a potential regulator of ES cell pluripotency and self-renewal is particularly intriguing given the evidence pointing to a tumor suppressor role for this miRNA in numerous human malignancies. Human tumors and cancer cell lines from colorectal, breast, prostate, and cervical carcinomas frequently exhibit reduced expression of miR-145 and miR-143. Functional studies including in vitro analyses of cell proliferation and survival as well as xenograft experiments demonstrate the potent antitumorigenic activity of these miRNAs (Sachdeva et al., 2009) . miR-145 directly targets multiple canonical oncogenic pathways, including those controlled by Ras and Myc (Chen et al., 2009; Sachdeva et al., 2009) , providing a mechanistic basis for these findings. Given the newly appreciated role of miR-145 in ES cell biology, loss of function of this miRNA may also potentiate tumorigenesis by promoting a program of aberrant self-renewal in preneoplastic cells. Indeed, the initial data suggesting that miR-145 has tumor suppressor activity came from the analysis of colorectal adenocarcinoma (Michael et al., 2003) , a tumor type likely to MicroRNAs of the miR-302 and miR-371 families have been implicated in the maintenance of the selfrenewal programs of human ES cells by targeting multiple cell cycle regulatory proteins. Core regulators of human ES cell pluripotency-OCT4, SOX2, and KLF4-are targeted directly by miR-145, ensuring that the tight control of ES cell proliferation and differentiation is maintained (Xu et al., 2009) . Reciprocal inhibition of miR-145 and OCT4 may contribute to irreversible silencing of self-renewal and pluripotency programs upon initiation of ES cell differentiation. Conversely, many tumors underexpress miR-145, suggesting that this miRNA might function more generally to maintain differentiated, nonproliferative states.
arise from colonic crypt stem cells that have lost the normal restraints on selfrenewal. Further investigation is needed to directly assess to what extent the activities and targets of miR-145 in ES cells are relevant to its tumor-suppressive effects.
In light of the Xu et al. study, it is instructive to consider the groundbreaking genetic analyses of lin-4 in the worm Caenorhabditis elegans almost 30 years ago. In these studies, the authors reasoned that this gene product (later determined to be an miRNA) acted as a suppressor of self-renewal of multiple worm cell lineages (Chalfie et al., 1981) . Subsequent work identified lin-28, a factor now known to be associated with pluripotency in mammals, as a target of lin-4 and its mammalian orthologs (Nimmo and Slack, 2009 ). The new work of Xu and colleagues reveals a parallel pathway through which miR-145 acts to silence multiple pluripotency factors during the switch from self-renewal to lineage commitment. These similarities predict that inactivation of miR-145 might broadly influence diverse stem cell lineages, a hypothesis that awaits direct testing through loss-of-function studies in animals.
